153 related articles for article (PubMed ID: 12064923)
1. Amelioration of painful crises in sickle cell disease by venesections.
Rombos Y; Tzanetea R; Kalotychou V; Konstantopoulos K; Simitzis S; Tassiopoulos T; Aessopos A; Fessas P
Blood Cells Mol Dis; 2002; 28(2):283-7. PubMed ID: 12064923
[TBL] [Abstract][Full Text] [Related]
2. Day-care management of sickle cell painful crisis in Jamaica: a model applicable elsewhere?
Ware MA; Hambleton I; Ochaya I; Serjeant GR
Br J Haematol; 1999 Jan; 104(1):93-6. PubMed ID: 10027718
[TBL] [Abstract][Full Text] [Related]
3. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.
de Abood M; de Castillo Z; Guerrero F; Espino M; Austin KL
Contraception; 1997 Nov; 56(5):313-6. PubMed ID: 9437560
[TBL] [Abstract][Full Text] [Related]
4. [Acute painful crisis in a female Nigerian patient with sickle cell disease].
Nin S; Seki M; Maie K; Kuroda A; Miyamoto K; Ogawa S; Ito Y; Kurita N; Yokoyama Y; Sakata Yanagimoto M; Obara N; Hasegawa Y; Ogino Y; Ito T; Chiba S
Rinsho Ketsueki; 2015 Jan; 56(1):30-4. PubMed ID: 25745965
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of sickle cell crises with multiple phlebotomies].
Bouchaïr N; Manigne P; Kanfer A; Raphalen P; de Montalembert M; Hagege I; Verschuur A; Maier-Redelsperger M; Girot R
Arch Pediatr; 2000 Mar; 7(3):249-55. PubMed ID: 10761600
[TBL] [Abstract][Full Text] [Related]
6. Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises.
Hagedorn JM; Monico EC
Pediatr Emerg Care; 2019 Jan; 35(1):78-79. PubMed ID: 27902670
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Terrin ML; Moore RD; Dover GJ; Barton FB; Eckert SV; McMahon RP; Bonds DR
N Engl J Med; 1995 May; 332(20):1317-22. PubMed ID: 7715639
[TBL] [Abstract][Full Text] [Related]
8. The painful crisis of homozygous sickle cell disease: clinical features.
Serjeant GR; Ceulaer CD; Lethbridge R; Morris J; Singhal A; Thomas PW
Br J Haematol; 1994 Jul; 87(3):586-91. PubMed ID: 7993801
[TBL] [Abstract][Full Text] [Related]
9. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy.
Adams PC; Kertesz AE; Valberg LS
J Clin Gastroenterol; 1993 Apr; 16(3):207-10. PubMed ID: 8505491
[TBL] [Abstract][Full Text] [Related]
10. The painful crisis of homozygous sickle cell disease. A study of the risk factors.
Baum KF; Dunn DT; Maude GH; Serjeant GR
Arch Intern Med; 1987 Jul; 147(7):1231-4. PubMed ID: 3606281
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pain in adults with sickle cell disease.
Ballas SK
Am J Hematol; 1990 May; 34(1):49-54. PubMed ID: 2183594
[TBL] [Abstract][Full Text] [Related]
12. A case of sickle-cell erythrocytosis occurring following renal transplantation.
Myers B; Donohue SM
Clin Lab Haematol; 2002 Jun; 24(3):175-7. PubMed ID: 12067283
[TBL] [Abstract][Full Text] [Related]
13. Overt iron deficiency in sickle cell disease.
Haddy TB; Castro O
Arch Intern Med; 1982 Sep; 142(9):1621-4. PubMed ID: 7114979
[TBL] [Abstract][Full Text] [Related]
14. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease.
Alvim RC; Viana MB; Pires MA; Franklin HM; Paula MJ; Brito AC; Oliveira TF; Rezende PV
Acta Haematol; 2005; 113(4):228-33. PubMed ID: 15983428
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells.
Ballas SK
Am J Hematol; 1991 Feb; 36(2):122-30. PubMed ID: 1707225
[TBL] [Abstract][Full Text] [Related]
16. Piracetam for reducing the incidence of painful sickle cell disease crises.
Al Hajeri AA; Fedorowicz Z; Omran A; Tadmouri GO
Cochrane Database Syst Rev; 2007 Apr; (2):CD006111. PubMed ID: 17443614
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
18. Improvement of sickle cell anemia by iron-limited erythropoiesis.
Castro O; Poillon WN; Finke H; Massac E
Am J Hematol; 1994 Oct; 47(2):74-81. PubMed ID: 7522396
[TBL] [Abstract][Full Text] [Related]
19. Painful crises in sickle cell disease--patients' perspectives.
Murray N; May A
BMJ; 1988 Aug; 297(6646):452-4. PubMed ID: 3139140
[TBL] [Abstract][Full Text] [Related]
20. Urinary creatine: biochemical indicator for evaluation of sickle cell crises.
Beyer C; Statius van Eps LW; Kastelein JJ; Brandjes DP; Mairuhu WM; van den Ende A
Clin Chem; 1985 Jul; 31(7):1232-4. PubMed ID: 4006197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
